Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannell

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Bone Marrow Transplantation|July 6, 2004
A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantationJ Moore, D Ma, R Will, et al.
Journal of Hematotherapy|August 1, 1997
Collection and recruitment of CD34+ cells during large-volume leukapheresisG Cull, J Ivey, P Chase, et al.
Leukemia|April 1, 1995
Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemiaJ O'Reilly, B Meyer, D Baker, et al.
Internal Medicine Journal|April 18, 2009
Safety and efficacy results from an international expanded access programme to bortezomib for patients with relapsed and/or refractory multiple myeloma: a subset analysis of the Australian and New Zealand data of 111 patientsH Quach, N Horvath, P Cannell, et al.
Internal Medicine Journal|September 9, 2015
Red cell and platelet transfusion burden following myeloablative allogeneic haemopoietic stem cell transplantationA Le Viellez, S P'Ng, S Buffery, et al.
Internal Medicine Journal|October 11, 2011
Cord blood transplantation in Western AustraliaD Purtill, J Cooney, P Cannell, et al.
Human Immunology|March 16, 2000
Unrelated donors selected prospectively by block-matching have superior bone marrow transplant outcomeC Witt, D Sayer, F Trimboli, et al.
Patient Education and Counseling|March 11, 2009
When the safety net of treatment has been removed: patients' unmet needs at the completion of treatment for haematological malignanciesE A Lobb, D Joske, P Butow, et al.
Internal Medicine Journal|March 18, 2009
The thrombotic thrombocytopenic purpura registry: a new national resource to inform patient care and medical researchM N Polizzotto, L E Phillips, P Cannell, et al.
Leukemia|October 27, 1997
Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment responseL Foroni, L A Coyle, M Papaioannou, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Bone Marrow Transplantation|July 6, 2004
A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantationJ Moore, D Ma, R Will, et al.
Journal of Hematotherapy|August 1, 1997
Collection and recruitment of CD34+ cells during large-volume leukapheresisG Cull, J Ivey, P Chase, et al.
Leukemia|April 1, 1995
Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemiaJ O'Reilly, B Meyer, D Baker, et al.
Internal Medicine Journal|April 18, 2009
Safety and efficacy results from an international expanded access programme to bortezomib for patients with relapsed and/or refractory multiple myeloma: a subset analysis of the Australian and New Zealand data of 111 patientsH Quach, N Horvath, P Cannell, et al.
Internal Medicine Journal|September 9, 2015
Red cell and platelet transfusion burden following myeloablative allogeneic haemopoietic stem cell transplantationA Le Viellez, S P'Ng, S Buffery, et al.
Internal Medicine Journal|October 11, 2011
Cord blood transplantation in Western AustraliaD Purtill, J Cooney, P Cannell, et al.
Human Immunology|March 16, 2000
Unrelated donors selected prospectively by block-matching have superior bone marrow transplant outcomeC Witt, D Sayer, F Trimboli, et al.
Patient Education and Counseling|March 11, 2009
When the safety net of treatment has been removed: patients' unmet needs at the completion of treatment for haematological malignanciesE A Lobb, D Joske, P Butow, et al.
Internal Medicine Journal|March 18, 2009
The thrombotic thrombocytopenic purpura registry: a new national resource to inform patient care and medical researchM N Polizzotto, L E Phillips, P Cannell, et al.
Leukemia|October 27, 1997
Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment responseL Foroni, L A Coyle, M Papaioannou, et al.
Pageof 3